Drug-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting
M. Michaelis, M. N. Wass, I. Reddin, Y. Voges, F. Rothweiler, S. Hehlgans, J. Cinatl, M. Mernberger, A. Nist, T. Stiewe, F. Roedel, J. Cinatl
The paper investigates drug-induced heterogeneity in cancer cell lines and identifies biomarkers for acquired resistance to YM155.
bioRxiv · Feb 13, 2020Pharmacology & Toxicology